Study: Kiva Augmentation System May Improve Vertebral Metastases Pain

A recent European study of the Kiva VCF treatment system for osteolytic vertebral metastases showed relevant improvement in pain and functional improvement in patients.

Advertisement

The single-arm study included 40 patients who underwent vertebral augmentation with the Kiva PEEK-OPTIMA implant. The results were published in Pain Physician Journal.

The device by Santa Clara, Calif.-based Benvenue Medical could present a new treatment option for patients with vertebral metastases — malignant bone tumors that can cause spine collapse — where other therapies may not be an option, according to the release.

More Articles on Materials Management:
Regentis Biomaterials Receives European Approval for Orthopedic Implant
Zimmer Looking to Grow Emerging Orthopedic Markets
Stryker Launches Spinal Pedicle Screw

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.